Flexible RSV Prefusogenic Fusion Glycoprotein Exposes Multiple Neutralizing Epitopes that May Collectively Contribute to Protective Immunity
Nita Patel(Novavax (United States)), Gale Smith(Novavax (United States))
Cited by 22
Related Papers
SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice
|Nature Communications|2021|524
Flexible RSV prefusogenic fusion glycoprotein exposes multiple neutralizing epitopes that may collectively contribute to protective immunity
|bioRxiv (Cold Spring Harbor Laboratory)|2020|10